Research & Development
Moderna's COVID-19 contractual vaccine orders for governments on track for April 2021
7 April 2021 -

US pharmaceutical and biotechnology company Moderna Inc (NASDAQ:MRNA) has said that deliveries of its COVID-19 vaccine are on track to meet the number of doses previously communicated to governments, Reuters news agency reported on Wednesday.

According to an email sent to Reuters from the company: "Moderna is committed to meeting all quarterly contractual delivery agreements with the European Commission and individual Member States."

Based in Cambridge, Massachusetts, Moderna focuses on drug discovery, drug development and vaccine technologies based on messenger RNA (mRNA).



Related Headlines